Drug Profile
Englitazone
Alternative Names: CP 68722; CP 72467 02; CP 72467 2Latest Information Update: 29 Mar 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Nonindustrial source; Pfizer
- Class Antihyperglycaemics; Antihyperlipidaemics; Small molecules; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 29 Mar 2000 No-Development-Reported for Type-2 diabetes mellitus in United Kingdom (Unknown route)
- 08 Nov 1999 Discontinued-I for Type-2 diabetes mellitus in USA (Unknown route)
- 16 Sep 1997 Preclinical development for Type-2 diabetes mellitus in United Kingdom (Unknown route)